Table 3.
Clinicopathological parameters | No. Case | HAX-1 Expression, n | P | ||||
---|---|---|---|---|---|---|---|
-~+ | ++ | +++ | |||||
Gender | 0.767 | ||||||
Male | 33 | 14 | 14 | 5 | |||
Female | 27 | 9 | 13 | 5 | |||
Age | 0.553 | ||||||
<60 | 5 | 2 | 3 | 0 | |||
≥60 | 55 | 21 | 24 | 10 | |||
Thickness | 0.014* | ||||||
<2 mm | 14 | 9 | 5 | 0 | |||
2-5 mm | 15 | 2 | 11 | 2 | |||
>5 mm | 31 | 12 | 11 | 8 | |||
TNM stages | 0.027* | ||||||
Tis | 6 | 6 | 0 | 0 | |||
I | 30 | 12 | 14 | 4 | |||
II | 20 | 5 | 10 | 5 | |||
III | 4 | 0 | 3 | 1 | |||
Differentiation | 0.007* | ||||||
Well | 25 | 12 | 12 | 1 | |||
Moderately | 25 | 11 | 10 | 4 | |||
Poorly | 10 | 0 | 5 | 5 | |||
Sites | 0.807 | ||||||
Sunlight exposure | 58 | 22 | 26 | 10 | |||
Non exposure | 2 | 1 | 1 | 0 | |||
* represents statistical significance, P<0.05.